Close

Modelling and economic evaluation for vaccine decision-making in Japan (Joint PhD 2027/28)

Supervisory team

Nagasaki University

  • Lead supervisor: Noriko Kitamura, Nagasaki University & Japan Institute for Health Security ([email protected])
  • Third supervisor: Hyolim Kang ([email protected])
  • Fourth supervisor: Motoi Suzuki, Nagasaki University & JIHS (Japan Institute for Health Security ([email protected])

LSHTM

The project

Background

Japan’s vaccine gap emerged partly from safety concerns surrounding MMR vaccination in the late 1980s, which led to its withdrawal in 1993. The resulting loss of public confidence and cautious policy decisions contributed to delays in the widespread introduction of multiple vaccines available elsewhere. Subsequent immunization reforms have progressively narrowed this gap by expanding access to routine vaccination.

To bring Japan’s future immunisation programmes to international standards, the new vaccination programme should be assessed from the aspects of effectiveness, safety, equity, acceptability, and cost-effectiveness following the WHO’s Evidence to Recommendation Framework.

Proposed project

The research will include two phases. The first phase of the research will focus on a comparative analysis of the vaccine decision-making processes in Japan (Japan NITAG - National Immunization Technical Advisory Group) and the UK (UK JCVI - Joint Committee on Vaccination and Immunisation) at the national level. This will be further compared with the WHO SAGE (Strategic Advisory Group of Experts on Immunization) decision-making process at the global level.

The second phase of the research will focus on timely policy-relevant analysis for vaccine decision-making in the Japan context for the next 5-10 years. The student will identify and study 1-3 research questions, such as: 

  • Dose change (e.g., 1-dose HPV vs 2-dose HPV vaccination) 
  • Optimizing target ages (e.g., age-escalation for HPV vaccine eligibility) 
  • Component change/addition to combination vaccines (e.g., MMRV/DTP-Hib-HepB-IPV)  
  • Schedule changes (e.g., DTP booster doses and TdaP)

The research will involve reviewing the epidemiology of the potential priority vaccine to be introduced in Japan and developing transmission dynamic models to understand the infectious disease dynamics of the target pathogens. These models will be impactful for assessing the health impact (i.e., benefits through reduction in disease burden versus potential vaccine-attributable risk) and economic impact (cost-effectiveness and budget impact) of different vaccination strategies. Potential research includes simulation case studies such as optimising the target age group and dosing intervals for multi-dose regimens.

The student is expected to split their time between Tokyo, Nagasaki, and London, with a significant amount of time spent at JIHS in Tokyo since some data are accessible only through secure access within the JIHS campus in Tokyo. Further, the time spent in JIHS and Tokyo will enable the student to liaise with stakeholders involved in the national decision-making process for vaccines in Japan, and align their research to the national immunisation programmes and policies in Japan.

References

The role of LSHTM and NU in this collaborative project

LSHTM hosts the Vaccine Centre, CMMID (Centre for Mathematical Modelling of Infectious Diseases), and GHECO (Global Health Economics Centre). The student will gain from this transdisciplinary research environment, resources, and expertise of cross-cutting interest to the proposed project.

Nagasaki University hosts the Department of Infectious Disease Epidemiology and Dynamics, whose mission is to advance infectious disease prevention and control through epidemiological research, mathematical modelling, design and evaluation of medical countermeasures and public health interventions, and specialist education in infectious disease epidemiology, modelling, and vaccinology.

The Japan Institute for Health Security (JIHS) is a national public health agency established in 2025 through the merger of the National Center for Global Health and Medicine (NCGM) and the National Institute of Infectious Diseases (NIID) to serve as Japan’s central hub for infectious disease intelligence, scientific research, and clinical crisis response.

LSHTM, Nagasaki University, and JIHS are partners in Japan AMED’s SCARDA (Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response) programme. The student will leverage the resources in this well-established collaboration framework. Co-supervisors Motoi Suzuki and Kaja Abbas serve on the Japan NITAG and UK JCVI committees, respectively, and they will facilitate access for the student to the non-confidential aspects of the functioning of these national vaccine policy committees.

Particular prior educational requirements for a student undertaking this project

Essential

  • Knowledge of infectious disease epidemiology.

Desired

  • Experience in vaccinology and infectious disease modelling;
  • Proficiency in Japanese.

The student is expected to split their time between Tokyo, Nagasaki, and London, with a significant amount of time spent at JIHS in Tokyo.

Skills we expect a student to develop/acquire whilst pursuing this project

  • Measure the disease burden from epidemiological studies 
  • Benefit-risk assessment of new vaccines 
  • Vaccine impact modelling 
  • Cost-effectiveness analysis.